25-OH Vitamin D: Evidence-Based Ways to Improve Your Level

What 25-OH Vitamin D Actually Measures

The 25-hydroxyvitamin D blood test (also written as 25(OH)D) is the standard biomarker for total body vitamin D status. Your liver converts dietary and sun-derived vitamin D into 25-hydroxyvitamin D, the circulating storage form with a half-life of approximately 15 days [1]. This is the form that clinicians order because it reflects cumulative intake from all sources (supplements, food, and UVB exposure) over the prior 4 to 8 weeks.

A common point of confusion: 25-OH vitamin D is not the active hormone. The kidneys convert it into 1,25-dihydroxyvitamin D (calcitriol), which regulates calcium absorption and bone remodeling. But calcitriol has a short half-life of about 4 to 6 hours, making it a poor marker for overall stores [2]. Ordering the wrong test can lead to a false sense of adequacy. The Endocrine Society's 2024 guideline reaffirms that 25(OH)D is the only appropriate screening assay for vitamin D status.

Two assay formats exist: immunoassay and liquid chromatography-tandem mass spectrometry (LC-MS/MS). LC-MS/MS separately quantifies D2 and D3 metabolites, which matters when a patient takes ergocalciferol (D2). If your lab reports only total 25(OH)D, both forms are summed.

Normal Ranges and What the Guidelines Say

The answer depends on which guideline you follow. That tension is worth understanding before you choose a dose.

The National Academies report and current NIH guidance classify serum 25(OH)D of at least 20 ng/mL as adequate for most people [3]. The Endocrine Society's 2024 guideline no longer endorses a universal 30 ng/mL target for disease prevention because clinical trials have not established an outcome-specific threshold [25]. People with a diagnosed deficiency, osteoporosis, malabsorption, or another treatment indication need condition-specific interpretation rather than a single population target.

A 2017 review by Michael Holick argued for higher vitamin D thresholds [5], but that is an expert viewpoint rather than a universal target adopted by the 2024 Endocrine Society guideline [25].

The practical takeaway is to interpret the number in context. Values below 12 ng/mL are deficient under current NIH guidance, values from 12 to under 20 ng/mL are generally inadequate, and at least 20 ng/mL is adequate for most people [14]. A result alone does not determine a loading dose, and higher is not automatically better.

Step 1: Correct Deficiency with a Loading Protocol

For patients with confirmed deficiency (25(OH)D <20 ng/mL), the Endocrine Society recommends 50,000 IU of ergocalciferol (D2) or cholecalciferol (D3) once weekly for 6 to 8 weeks, followed by a maintenance dose of 1,500 to 2,000 IU daily [4]. This is not a suggestion reserved for severe cases. It is the standard repletion protocol.

Cholecalciferol (D3) is preferred over ergocalciferol (D2) in most contexts. A meta-analysis of 7 RCTs (N=804) published in the American Journal of Clinical Nutrition found that D3 raised serum 25(OH)D levels approximately 87% more effectively than D2 and maintained those levels 2 to 3 times longer [6]. D2 is still appropriate for strict vegans (as plant-derived D2 comes from irradiated yeast), but D3 derived from lichen is now widely available as a vegan alternative.

One randomized trial tested a single annual dose of 500,000 IU and found more falls and fractures in the vitamin D group than in the placebo group (Sanders et al., PMID 20460620) [7]. That result is a warning against extrapolating from ordinary daily intake to very large bolus regimens.

Step 2: Establish a Daily Maintenance Dose

After repletion, the right maintenance dose depends on your body weight, baseline level, and absorption status. Here is a dose-response framework based on pooled data.

Each 1,000 IU of daily D3 raises 25(OH)D by roughly 6 to 10 ng/mL over 2 to 3 months in normal-weight adults [8]. That means a 140-pound person starting at 22 ng/mL could reach 32 to 42 ng/mL on 2,000 IU daily. A person at the same starting level who weighs 240 pounds might need 4,000 to 5,000 IU daily to achieve the same result, because vitamin D is fat-soluble and distributes into adipose tissue.

An older Endocrine Society deficiency guideline noted that people with obesity may require a different treatment dose [4]. A dose-response trial in 163 postmenopausal women also found that body size influenced the serum response to supplementation (Gallagher et al., PMID 22431675) [9]. Neither source establishes one maintenance dose for every person with a BMI of 30 or above.

Practical dosing tiers for maintenance:

• Normal weight (BMI <25): 1,500 to 2,000 IU/day
• Overweight (BMI 25 to 29.9): 2,000 to 3,000 IU/day
• Obese (BMI ≥30): 3,000 to 5,000 IU/day
• Post-bariatric surgery or malabsorption: 5,000 to 10,000 IU/day under physician monitoring

Always take vitamin D with a meal containing fat. A study by Dawson-Hughes et al. found that taking vitamin D with the largest meal of the day (which typically contains the most fat) increased absorption by approximately 50% compared to taking it on an empty stomach [10].

Step 3: Optimize Sun Exposure (Within Limits)

Sunlight is the original source. When UVB radiation (wavelength 290 to 320 nm) strikes the skin, 7-dehydrocholesterol converts to previtamin D3. Roughly 10 to 30 minutes of midday sun exposure on the face, arms, and legs two to three times per week can produce 10,000 to 20,000 IU of vitamin D3 in fair-skinned individuals [5]. That number drops dramatically with darker skin pigmentation, sunscreen use, higher latitudes, and winter months.

The WHO and CDC do not endorse unprotected sun exposure as a primary vitamin D strategy due to skin cancer risk [11, 12]. The practical middle ground: if you live below the 37th parallel (roughly south of San Francisco, St. Louis, or Richmond) and have a Fitzpatrick skin type I to III, 10 to 15 minutes of unprotected midday sun on arms and legs a few times per week during spring through fall can meaningfully contribute to your vitamin D production. For everyone else, or during winter months, supplementation is more reliable.

A critical detail: UVB rays do not penetrate glass. Sitting near a sunny window does not generate vitamin D. And SPF 30 sunscreen blocks approximately 95 to 98% of UVB, effectively halting cutaneous vitamin D synthesis [13].

Step 4: Add Dietary Sources

Diet alone rarely corrects deficiency. Few foods contain meaningful amounts of vitamin D. But dietary sources can contribute 200 to 600 IU per day, which helps sustain levels once you have repleted.

The richest natural sources per 3-ounce serving: wild-caught salmon provides 600 to 1,000 IU, canned sockeye salmon about 570 IU, sardines roughly 165 IU, and a single egg yolk about 40 IU [14]. Farmed salmon contains significantly less vitamin D than wild-caught, sometimes 75% less, due to differences in feed composition.

Fortified foods add modest amounts. One cup of fortified milk or orange juice typically contains 100 to 120 IU. Fortified cereals range from 40 to 100 IU per serving. UV-exposed mushrooms (now sold in many grocery stores) can provide 400 to 800 IU per serving, though this is primarily D2, which, as noted above, is less potent at raising serum levels [6].

The National Institutes of Health Office of Dietary Supplements provides a complete nutrient database. Their recommended dietary allowance (RDA) of 600 IU for adults under 70 and 800 IU for adults 71 and older was set by the IOM in 2011, but the Endocrine Society and the American Association of Clinical Endocrinologists (AACE) consider these values insufficient for patients already found to be deficient [4, 15].

The Role of Vitamin K2 and Magnesium

Two cofactors deserve attention because they influence how well your body uses the vitamin D you take.

Magnesium is required for the enzymatic conversion of vitamin D into its active form. A cross-sectional analysis from the NHANES dataset (N=12,284) found that adequate magnesium intake was significantly associated with reduced risk of vitamin D deficiency and insufficiency [16]. The American Osteopathic Association published a review noting that "vitamin D supplementation without adequate magnesium can be ineffective" because the enzymes that metabolize vitamin D (hepatic 25-hydroxylase and renal 1α-hydroxylase) are magnesium-dependent [17]. Good magnesium sources include pumpkin seeds (156 mg per ounce), spinach (157 mg per cup cooked), and magnesium glycinate supplements (typical dose: 200 to 400 mg/day).

Vitamin K2 (menaquinone-7) directs calcium into bones and away from arterial walls. While no large RCT has definitively proven that adding K2 to vitamin D supplementation improves bone outcomes beyond vitamin D alone, a 3-year trial in postmenopausal women (N=244) showed that K2 (180 mcg/day MK-7) reduced age-related bone mineral density loss at the lumbar spine and femoral neck [18]. Many clinicians now recommend 100 to 200 mcg of MK-7 alongside vitamin D supplementation, especially in patients at risk for vascular calcification.

When to Retest and What to Watch For

Retest 25(OH)D at 3 months after starting supplementation or changing dose. Testing earlier is unreliable because it takes 8 to 12 weeks for serum levels to stabilize at the new steady state [4].

If your level has not improved after 12 weeks on an adequate dose, consider these factors: malabsorption (celiac disease, Crohn's, history of gastric bypass), liver disease (impaired 25-hydroxylation), medication interference (phenytoin, phenobarbital, and carbamazepine accelerate vitamin D catabolism through CYP450 induction), or simple non-adherence.

The USPSTF does not recommend universal screening for vitamin D deficiency in asymptomatic adults, stating that current evidence is insufficient to assess the balance of benefits and harms [19]. However, testing is clearly indicated in patients with osteoporosis, chronic kidney disease, malabsorption syndromes, obesity, unexplained muscle weakness, or frequent falls.

When Vitamin D Is Too High

Vitamin D toxicity is uncommon but real and usually results from excessive supplemental intake rather than sun exposure [14, 20]. The adult UL is 4,000 IU/day for routine intake [14]. That population safety boundary is not a personal guarantee below 4,000 IU and does not define the dose at which toxicity begins.

The hallmark of vitamin D toxicity is hypercalcemia. Symptoms include nausea, vomiting, polyuria, confusion, and in severe cases, renal failure and cardiac arrhythmias. A 25(OH)D level above 100 ng/mL is the usual threshold where hypercalcemia risk becomes clinically relevant [20]. Levels between 50 and 100 ng/mL are not associated with toxicity in most studies but offer no proven additional benefit for most patients [3].

If your 25(OH)D is above 80 ng/mL without a clinical reason (such as granulomatous disease requiring monitoring), reducing or stopping supplementation and rechecking in 3 months is the standard approach.

Special Populations

Older adults (65+): Skin production of vitamin D declines with age [5]. A 2014 American Geriatrics Society consensus statement recommended at least 1,000 IU/day of vitamin D supplementation for most older adults to reduce fall and fracture risk, while emphasizing total intake and individual clinical circumstances (PMID 24350602) [21]. Current prevention guidance should also be considered because recommendations have evolved [25].

Darker skin tones: Melanin reduces UVB-mediated vitamin D synthesis by 50 to 90% compared to Fitzpatrick type I skin. NHANES data show that 82% of non-Hispanic Black Americans and 63% of Hispanic Americans have 25(OH)D levels below 20 ng/mL, compared to 31% of non-Hispanic white Americans [22]. Supplementation rather than sun exposure is the primary corrective strategy for these groups.

Pregnant and lactating women: The American College of Obstetricians and Gynecologists (ACOG) recommends 600 IU/day as the minimum, though many experts advocate for 2,000 to 4,000 IU/day during pregnancy based on data from a trial by Hollis et al. (N=350) showing that 4,000 IU/day safely achieved levels above 40 ng/mL without adverse effects in pregnant women [23, 24].

Patients on GLP-1 receptor agonists: Rapid weight loss from medications like semaglutide or tirzepatide can release stored vitamin D from adipose tissue, transiently raising serum levels. However, as fat mass decreases, the body's vitamin D storage capacity also decreases, and patients may need dose adjustments during active weight-loss phases. Monitor 25(OH)D every 3 to 6 months during GLP-1 therapy.

A Concrete 12-Week Action Plan

Week 1: Review the result, current supplements, calcium, kidney function, medications, and the reason the test was ordered. Do not convert a single result into a high-dose regimen without checking for conditions that change vitamin D metabolism.

Weeks 1 through 8: If a clinician prescribes repletion for documented deficiency, follow that product, dose, and duration. Use food to help meet calcium and vitamin D intake goals. Magnesium or vitamin K supplements are not automatic requirements and should be based on diet, medications, and the treatment plan.

Weeks 9 through 12: Reassess adherence, symptoms, and whether follow-up testing is appropriate for the indication. A maintenance dose should reflect the measured response and total intake, not body weight alone.

At follow-up: Interpret the new value using the same clinical indication that justified treatment. The 2024 Endocrine Society prevention guideline does not define 40 to 60 ng/mL as a universal target [25]. An unexpected response can prompt a review of absorption, medications, dosing accuracy, and the original diagnosis rather than automatic repetition of a loading regimen.